Dosimetric and radiobiological comparison of prostate VMAT plans optimized using the photon and progressive resolution algorithm

核医学 剂量体积直方图 前列腺 医学 剂量学 放射治疗计划 放射治疗 算法 数学 放射科 癌症 内科学
作者
J Chow,Runqing Jiang,Lu Xu
出处
期刊:Medical Dosimetry [Elsevier]
卷期号:45 (1): 14-18 被引量:5
标识
DOI:10.1016/j.meddos.2019.04.004
摘要

This study compared the dosimetric and radiobiological parameters of prostate volumetric modulated arc therapy (VMAT) plans using different prescriptions optimized by the photon optimization (PO) and progressive resolution optimization (PRO) algorithm. A total of 20 prostate patients were selected retrospectively and divided into 2 groups of VMAT plans using prescriptions of 60 Gy/20 fx and 79 Gy/38 fx. Inverse treatment planning optimized by the PO and PRO algorithm based on the dual-arc technique was carried out by the Eclipse treatment planning system. The maximum dose, minimum dose, mean dose, dose-volume points, and dose-volume indices of the targets and organs at risk (OAR) were calculated from the plans. In addition, radiobiological parameters such as tumor control probability (TCP), normal tissue complication probability (NTCP), and equivalent uniform dose (EUD) of the targets and OAR were determined based on their dose-volume histograms (DVHs). A paired Student's t-test was carried out to compare the difference between mean dose-volume points, radiobiological parameters, and dose-volume indices. Two-tailed p < 0.05 was defined as having statistical difference. For prostate VMAT plans optimized by the PO algorithm, equal or slightly larger mean dose and TCP of the PTV (1% for 60 Gy/20 fx and 0.2% for 78 Gy/39 fx) were found by comparing to the PRO. These were followed by finding the slightly larger conformity index (CI; 0.927 vs 0.895 and 0.910 vs 0.904), larger or equal homogeneity index (HI; 0.054 vs 0.052 and 0.058 vs 0.058), and smaller gradient index (GI; 1.366 vs 2.288 and 1.585 vs 1.742) of the PTV using plans optimized by the PO vs PRO using prescriptions of 60 Gy/20 fx and 78 Gy/39 fx. For the OAR, we found that the mean doses, NTCPs, and EUDs of the rectum, bladder, and femur were slightly larger for plans optimized by the PO algorithm compared to the PRO, though both optimization algorithms satisfied all the dose-volume criteria and objectives in the inverse planning. Both the PO and PRO algorithm can generate prostate VMAT plans fulfilling the required dose-volume criteria. It is concluded that plans optimized by the PO algorithm can produce prostate plan with very similar quality compared to PRO.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
波特卡斯D艾斯完成签到 ,获得积分10
刚刚
852应助排骨炖豆角采纳,获得10
1秒前
1秒前
顾矜应助木子采纳,获得10
1秒前
feng发布了新的文献求助10
1秒前
成就的小熊猫完成签到,获得积分10
2秒前
2秒前
Morgenstern_ZH完成签到,获得积分10
3秒前
hua发布了新的文献求助10
3秒前
_Forelsket_完成签到,获得积分10
3秒前
3秒前
半颗橙子完成签到 ,获得积分10
5秒前
科研通AI5应助zmy采纳,获得10
5秒前
善学以致用应助enoot采纳,获得10
6秒前
JamesPei应助失眠的血茗采纳,获得10
6秒前
青山发布了新的文献求助10
6秒前
亻鱼发布了新的文献求助10
7秒前
脑洞疼应助成就的小熊猫采纳,获得10
7秒前
7秒前
waterclouds完成签到 ,获得积分10
7秒前
圆圈儿完成签到,获得积分10
7秒前
司空剑封完成签到,获得积分10
8秒前
8秒前
海棠yiyi完成签到,获得积分10
8秒前
8秒前
梁小鑫发布了新的文献求助10
8秒前
Jenny应助圈圈采纳,获得10
9秒前
内向青文完成签到,获得积分10
9秒前
lefora完成签到,获得积分10
9秒前
丰知然应助CO2采纳,获得10
10秒前
Zhihu完成签到,获得积分10
10秒前
feng完成签到,获得积分10
11秒前
11秒前
美丽稀完成签到,获得积分10
12秒前
PXY应助屁王采纳,获得10
12秒前
sunburst完成签到,获得积分10
12秒前
狼主完成签到 ,获得积分10
12秒前
吕亦寒完成签到,获得积分10
12秒前
junzilan发布了新的文献求助10
13秒前
ZL发布了新的文献求助10
13秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527521
求助须知:如何正确求助?哪些是违规求助? 3107606
关于积分的说明 9286171
捐赠科研通 2805329
什么是DOI,文献DOI怎么找? 1539901
邀请新用户注册赠送积分活动 716827
科研通“疑难数据库(出版商)”最低求助积分说明 709740